Sebastien Poulin

Hôpital De St Jérôme, St Jérôme
QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Journal: The New England journal of medicine

Published: June 17, 2026

Optimal timing of infant post-vaccination serological testing for hepatitis B virus immunity.

Optimal timing of infant post-vaccination serological testing for hepatitis B virus immunity.

Journal: Canadian liver journal

Published: May 14, 2026

Barriers to Hepatitis B Treatment: A Multicentre Cross-Sectional Registry and Survey Study by the Canadian Hepatitis B Network.

Barriers to Hepatitis B Treatment: A Multicentre Cross-Sectional Registry and Survey Study by the Canadian Hepatitis B Network.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: May 01, 2026

5' leader defects drive persistent HIV-1 viremia on long-term ART.

5' leader defects drive persistent HIV-1 viremia on long-term ART.

Journal: Nature communications

Published: October 21, 2025

Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia.

Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia.

Journal: Science translational medicine

Published: August 13, 2025

The Management of Chronic Hepatitis B: 2025 Guidelines Update from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada.

The Management of Chronic Hepatitis B: 2025 Guidelines Update from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada.

Journal: Canadian liver journal

Published: July 18, 2025

Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.

Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.

Journal: Journal of hepatology

Published: April 11, 2025

Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry.

Real-life experience with IV dalbavancin in Canada; results from the CLEAR (Canadian LEadership on Antimicrobial Real-life usage) registry.

Journal: Journal of global antimicrobial resistance

Published: April 25, 2024

Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B.

Sequential Peg-IFN after bepirovirsen may reduce post-treatment relapse in chronic hepatitis B.

Journal: Journal of hepatology

Published: January 12, 2024

Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak.

Monkeypox in Montréal: Epidemiology, Phylogenomics, and Public Health Response to a Large North American Outbreak.

Journal: Annals of internal medicine

Published: December 12, 2022

Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremia.

Clonally expanded HIV-1 proviruses with 5'-leader defects can give rise to nonsuppressible residual viremia.

Journal: The Journal of clinical investigation

Published: September 13, 2022

Broadly Neutralizing Antibodies for Human Immunodeficiency Virus Treatment: Broad in Theory, Narrow in Reality.

Broadly Neutralizing Antibodies for Human Immunodeficiency Virus Treatment: Broad in Theory, Narrow in Reality.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: August 12, 2022

Showing 1-12 of 15

Last Updated: 09/26/2026